Dermata Therapeutics's total assets for Q2 2024 were $5.24M, an increase of 1.10% from the previous quarter. DRMA total liabilities were $1.92M for the fiscal quarter, a 39.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.